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Background: Chronic infections have been demonstrated to maintain low-grade systemic inflammation and associate
with atherosclerosis. We studied the inflammation- and lipid homeostasis-related effects of Aggregatibacter
actinomycetemcomitans (Aa) and Chlamydia pneumoniae (Cpn) infections on the epididymal and inguinal adipose
tissue (AT) transcriptomes and fatty acid distribution in apolipoprotein (apo) E-deficient mice. Chow-fed apoE-deficient
mice were exposed to 1) chronic intranasal infection with C. pneumoniae (Cpn group), 2) recurrent intravenous
infection with A. actinomycetemcomitans (Aa group), 3) a combination of both types of infection (Cpn + Aa group), or
4) infection with the vehicle (control group). Epididymal and inguinal AT gene expression was analyzed using an
Illumina Mouse WG-6 v2.0 platform and quantitative PCR (QPCR). Microarray data were analyzed using Gene Ontology
enrichment analysis. AT fatty acid analysis was performed using gas–liquid chromatography.
Results: The transcriptomics data revealed significant enrichment in inflammation-associated biological pathways in
both AT depots derived from the Aa and Cpn + Aa treated mice compared with the control group. The proportion of
saturated fatty acids was higher in the inguinal AT in Aa (p = 0.027) and Cpn + Aa (p = 0.009) groups and in the
epididymal AT in Aa group (p = 0.003). The proportion of polyunsaturated fatty acids was significantly lower among all
Aa-infected groups in both depots. Chronic Cpn infection displayed only minor effects on transcriptomics and fatty
acids of the AT depots.
Conclusions: Systemic infection with A. actinomycetemcomitans activates inflammation-related biological pathways
and modulates cellular lipid homeostasis. The adverse changes in adipose tissues during chronic infection may
promote atherosclerosis.
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Atherosclerosis is an inflammatory disease with complex
multifactorial pathophysiology. In addition to the
chronic inflammation in the vessel wall causing vascular
endothelial dysfunction, the progression of the disease
may be enhanced by persistent systemic infection, low-
grade inflammation, and metabolic disturbances of
major organs such as liver and adipose tissue (AT).* Correspondence: kati.hyvarinen@helsinki.fi
1Institute of Dentistry, University of Helsinki, P.O. Box 63, 00014 Helsinki,
Finland
Full list of author information is available at the end of the article
© 2013 Hyvärinen et al.; licensee BioMed Cent
Commons Attribution License (http://creativec
reproduction in any medium, provided the orAT is a multi-functional metabolic organ composed of a
heterogeneous cell population. By storing and releasing
fatty acids and secreting several important adipokines, AT
plays a significant role in both energy metabolism and
homeostatic regulation of the endocrine system. The AT
dysfunction, followed by the spill-over of free fatty acids
(FFAs) into the circulation via enhanced lipolysis and
dysregulated expression of adipokines, modifies immune
responses and contributes to metabolic disorders such as
metabolic syndrome and type 2 diabetes [1,2].
AT depots are dispersed throughout the body and are
closely associated with several organs [3]. Recent studiesral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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istics in AT depots, i.e. differences in cell populations,
microvasculature, innervation, and regional variation in
metabolic functions including adipokine profiles, lipase
activities, uptake of fatty acids, and the insulin response
[4]. These differences have a major impact on the
proinflammatory potential of the various AT depots.
In humans, visceral AT has been shown to generate
angiotensin, interleukin (IL) -6, and plasminogen activa-
tor inhibitor (PAI)-1 at higher levels and leptin and
adiponectin at lower levels than subcutaneous AT [5].
Differences in hormone-sensitive lipase activity and
maximum lipolytic capacity between omental and sub-
cutaneous AT depots have been reported; however, these
phenomena seem to be strongly correlated to the adipo-
cyte size and their capacity to expand [6]. In obese
humans, perivisceral AT has been reported to contain
more saturated fatty acids (SFAs) and monounsaturated
fatty acids (MUFAs) than subcutaneous AT [7]. In mice,
high-fat feeding results in a continuous increase in adi-
pocyte size both in subcutaneous and visceral fat. Inter-
estingly, large adipocytes contain relatively more stearic
acid and oleic acid, and these cells produce more
tumour necrosis factor (TNF)-α, leptin, angiotensinogen,
adipsin, and PAI-1 compared with small adipocytes [8].
Although AT has considerable pro-inflammatory and
pro-atherogenic potential, and contributes to systemic in-
nate immune responses, the impact of chronic systemic in-
fections on AT is rarely investigated. Many pathogens
related to common chronic infections, such as gastritis,
periodontitis, and pulmonary infections, are lipopolysac-
charide (LPS) containing Gram-negative species. Although
LPS promotes inflammation mainly through its effects on
the monocyte/macrophage function, an in vitro study has
demonstrated that subcutaneous human adipocytes secrete
large quantities of TNF-α when activated by LPS [9].
Szalowska et al. 2011 have shown that LPS activation of
human omental fat results in up-regulated expression of
inflammation- and angiogenesis-related genes [10].
The periodontal pathogen Aggregatibacter actinomy-
cetemcomitans and the persistent pulmonary infection
agent Chlamydia pneumoniae are Gram-negative patho-
gens and associated with an increased risk for cardiovas-
cular diseases [11-13]. Both pathogens have been found
in human atherosclerotic lesions [11,14], accelerate ath-
erosclerosis in mouse model [15,16], and are highly
common among general population [17,18]. We have
recently shown in apolipoprotein E (apoE)-deficient
mouse model that systemic A. actinomycetemcomitans
and C. pneumoniae infections may induce broad range
pro-atherogenic effects including alterations in macro-
phage cholesterol homeostasis, endothelial function
[19], and, moreover, in the liver morphology, fatty acid
composition, and inflammation marker profile [20].In the present study, we investigated the effects of sys-
temic recurrent A. actinomycetemcomitans and chronic C.
pneumoniae infections on epididymal and inguinal AT de-
pots in apoE-deficient mice. In addition, combined infec-
tion model was used to study the impact of pathogen
burden on these depots. ApoE-deficient mice display a
proatherogenic plasma lipoprotein profile and they de-
velop atherosclerotic lesions on a chow diet. In addition,
due to decreased levels of LPS-neutralizing high-density
lipoproteins, apoE-deficient mice show increased suscepti-
bility to LPS-mediated inflammation compared to wild-
type mice [21]. In order to include both visceral and sub-
cutaneous AT and to identify their putative depot-specific
pro-inflammatory and pro-atherogenic potential, we uti-
lized both epididymal and inguinal AT depots. We fo-
cused on molecules associated with inflammation and
lipid homeostasis, which were investigated on the level of
gene expression and cellular fat composition.
Methods
Mice
Male apolipoprotein (apo) E-deficient mice (B6.129P2-
Apoetm1Unc/Crl) were purchased from Charles River La-
boratories. The mice were fed regular mouse chow ab
libitum and maintained in a germ-free environment at
the National Public Health Institute Animal Facilities
(Helsinki, Finland). Animal care and experimentation
were conducted under Animal Care and Use Committee
of National Public Health Institute ethical authorization
and were in accordance with the guidelines of the Coun-
cil of Europe.
Bacterial cultures, infection procedure, and serum analyses
The bacteria cultures and experimental design have
been previously reported [20]. Briefly, the clinical A.
actinomycetemcomitans strain AT445b (serotype b)
was cultivated in a tryptic soy-serum-bacitracin-vanco-
mycin medium at 37°C with 5% CO2 for 48 h. The C.
pneumoniae isolate, Kajaani 7, a Finnish epidemic strain,
was isolated and cultured as previously described [22].
The infection procedure is presented in Table 1. The ex-
perimental design included chronic C. pneumoniae infec-
tion model, which was achieved by three consecutive
inoculations, recurrent A. actinomycetemcomitans infec-
tion model mimicking repeated systemic exposure to the
pathogen, and a combination of these two infection mo-
dels to imitate the effects of infection burden. Chronic C.
pneumoniae infection was induced in younger mice e in
order to see the potential effect of persistence. Viable
C. pneumoniae (Cpn) was administered intranasally as
2 × 106 inclusion forming units in 40 μl of sucrose-
phosphate-glutamic acid buffer (SPG), and viable A.
actinomycetemcomitans (Aa) was administered intra-
venously (via the tail vein) as 1 × 107 colony forming
Table 1 Experimental design of the study
Study group Age (weeks)
9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
Cpn group ▪ ▪ ▪ †
Aa group ● ● ● ● ● ● ● ● ● ● †
Cpn + Aa group ▪ ▪ ▪ ● ● ● ● ● ● ● ● ● ● †
Control □ □ □ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ †
The black squares represent Cpn inoculations and the black circles Aa inoculations. The controls received the respective vehicle (white squares and circles). †,
sacrifice; Aa, A. actinomycetemcomitans; Cpn, C. pneumoniae.
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cluded four groups: 1) recurrent Aa infection group (Aa
group, n = 10) with ten Aa inoculations; 2) the chronic
Cpn infection group (Cpn group, n = 10) with three Cpn
inoculations; 3) the combined chronic Cpn and recurrent
Aa infection group (Cpn +Aa group, n = 10) with three
Cpn inoculations and ten Aa inoculations; and 4) the con-
trol group (n = 9) with three SPG inoculations and ten
0.9% NaCl inoculations.
The serum levels of nonesterified fatty acids (Waco
Chemicals GmbH), the LPS activity (HyCult biotechnol-
ogy b.v.), and the serum levels of TNFα (Pierce Biotech-
nology, Inc.) were measured as described in our previous
publications [19,20].
Preparation of adipose tissues
Inguinal and epididymal AT depots were carefully dis-
sected from sacrificed animals. The tissue specimens
were stabilized with RNAlater™ (Sigma) or snap-frozen
in liquid nitrogen. All the samples were stored at −70°C.
Isolation and quality evaluation of RNA
Epididymal and inguinal AT homogenization was perfor-
med with a Mixer Mill MM 301 (Retsch GmbH) and total
RNA was extracted using the RNeasy Lipid Tissue Mini
Kit (Qiagen). DNase treatment was performed on a col-
umn using the RNase-Free DNase Set (Qiagen) and again
after RNA extraction using the DNA-free™ Kit (Ambion).
The RNA concentration was determined using a
NanoDrop 1000 spectrophotometer (Thermo Scien-
tific). The quality of total RNA was assessed by an
Agilent 2100 Bioanalyzer using the Eukaryote Total
RNA Nano Kit (Agilent Technologies).
Adipose tissue RNA microarray processing
Inguinal and epididymal AT gene expression was ana-
lyzed using the Illumina Mouse WG-6 v2.0 platform.
Three biological replicates were used and the high qua-
lity total RNA (RNA integrity number ≥ 8.5) was ampli-
fied using the Illumina TotalPrep RNA Amplification Kit
according to the manufacturer’s instructions. Briefly, the
total RNA was reverse-transcribed using T7 Oligo(dT)
primers following the second strand cDNA synthesis.After purification, the cDNA was in vitro transcripted
into cRNA using biotin-labeled nucleoside triphos-
phates. The quality of biotinylated cRNA was assessed
by an Agilent 2100 Bioanalyzer and 1.5 μg of cRNA
from each sample was hybridized at 58°C overnight
using the Illumina Whole-Genome Gene Expression
Direct Hybridization Assay system with the six-sample
BeadChip platform. The signal was developed using
streptavidin-Cy3 and the BeadChips were scanned with
an Illumina BeadArray Reader.
Microarray data analyses
The microarray data has been deposited in MIAME-
compliant format in Gene Expression Omnibus (http://
www.ncbi.nlm.nih.gov/geo/), accession number GSE50647.
Gene ontology (GO) enrichment analysis for microarray
data was performed using the Fisher's exact test, where the
observed frequency of each present GO term was com-
pared with the frequency in a reference gene set (control
mice). P-values were corrected for multiple hypotheses
using the Benjamini-Hochberg false discovery rate [23].
The analyses were performed using the R Base Package
version 2.15.0. The maximum of 20 most enriched GO
terms were reported for both epididymal and inguinal AT
and ranked according to the p-value. To limit the data and
focus on the biologically meaningful pathways and molecu-
lar functions, GO terms referring to cellular components
were excluded. The fold-change (FC) limitation for the
presented up- and down-regulated genes was 2.0 except
when observing de novo lipogenesis-associated genes
where all results are present.
Quantitative real-time PCR
Epididymal and inguinal AT cDNA was synthesized from
total RNA using the ImProm-II™ Reverse Transcription sys-
tem (Promega). The amount of total RNA in each reverse
transcription (RT) reaction was 240 ng for the inguinal AT
and 500 ng for the epididymal AT. The number of mice in
each group was 10, except for the control group where 9
mice were used. Primers (Thermo Scientific) were designed
using Beacon Designer (Premier Biosoft International) and
National Center for Biotechnology Information Primer-
BLAST (http://www.ncbi.nlm.nih.gov/tools/primer-blast/)
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(Gapdh), monocyte chemoattractant protein 1 (Mcp-1),
macrophage migration inhibitory factor (Mif), mannose re-
ceptor C type 1 (Mrc-1), myeloperoxidase (Mpo), and
secretory leukocyte peptidase inhibitor (Slpi). Primer se-
quences are presented in Additional file 1: Table S1. Quan-
titative real-time PCR (QPCR) was performed using the
Mx3005 Real-Time QPCR System (Stratagene). The ana-
lyses were conducted in 12.5 μl reaction mixtures, each
containing 2 μl of 1:50 dilution of cDNA synthesized in
RT reaction, 6.25 μl of Brilliant SYBR® Green QPCR Mas-
ter Mix (Stratagene), 30 nM of ROX reference dye (Strata-
gene), and optimized concentrations of primers (100 nM,
except 200 nM for Gapdh). The amplifications were
performed using the following thermocycling program: ini-
tial denaturation at 95°C for 15 min, 40 cycles of 15 s at
95°C and 1 min at 60°C followed by melting curve analysis
for 1 min at 95°C, gradual decrease to 55°C, 30 s at 55°C,
gradual increase to 95°C, and 30 s at 95°C. All samples
were analyzed as duplicates and the accepted intra-assay
coefficient of variation for threshold cycle was ≤ 2.1%. The
results were analyzed using Mx3005 Real-Time QPCR Sys-
tem (Stratagene) software and expressed as a log2 fold
change (log2FC) to the respective control mice (level set to
zero in the analysis). Gapdh was used as a normalization
gene and the software utilizes modified comparative quan-
titation method introduced by Pfaffl (2001) [24].
Adipose tissue fatty acid analysis
Total lipids were extracted from 30–80 mg of epididymal
and inguinal adipose tissue with hexane-isopropanol (3:2)
[25] and trans-methylated by heating with acidic methanol
(5% H2SO4) [26]. The resulting fatty acid methyl ester
compositions were analyzed by gas–liquid partition chro-
matography using a Hewlett Packard 6890 Gas Chromato-
graph (ChemStation B.01.03 software) with a DB-225 GC
column (30 m, diameter 0.32 mm, phase layer 0.25 μm;
Agilent Technologies). The samples were split injected
with hydrogen as a carrier gas and the temperature pro-
gram was from 160°C to 230°C. The relative amounts of
the methylated fatty acids were expressed as percentages
of weight normalized to 100%.
Statistical analyses
The AT fatty acid data were expressed as mean percent-
ages of weight with standard deviations (SDs). The gene
expression data were expressed as log2 fold change
(log2FC) medians with interquartile ranges (IQRs). The
significance of the differences between the experimental
and control mouse groups was assessed using the non-
parametric Mann–Whitney U test. Bivariate correlations
were determined using the Spearman test. Analyses were
performed using PASW Statistics 18 (Statistical Package
for the Social Sciences).Results
Infection-enriched biological pathways in the inguinal AT
Infection-enriched biological pathways (i.e., GO terms)
and the associated up- and down-regulated genes in the
inguinal AT transcriptome are presented in Tables 2, 3
and 4. Compared with the control mice, the expression
of “Protein binding” pathway (GO:0005515) was increased
(p <0.001) most significantly in Aa group (Table 2). In
addition, the inflammation-related “Antigen binding”
(GO:0003823, p = 0.009), “Antibacterial humoral response”
(GO:0019731, p = 0.009), and “Antimicrobial humoral re-
sponse” (GO:0019730, p = 0.009) pathways were signifi-
cantly enriched (Table 2).
Compared with the control mice, most of the enriched
GO terms in the inguinal AT transcriptome of Cpn
group were pathways associated with development- and
morphogenesis (Table 3). The most affected pathway
was “Negative regulation of cellular process” pathway
(GO:0048523, p = 0.036).
The most significantly enriched pathway in the in-
guinal AT transcriptome of Cpn + Aa group was
“Protein binding” (GO:0005515, p <0.001) followed by
inflammation-related “Antigen binding” (GO:0003823,
p <0.001), “Antibacterial humoral response” (GO:0019731,
p = 0.002), and “Antimicrobial humoral response”
(GO:0019730, p = 0.002) pathways (Table 4). Lipid homeo-
stasis-related “Regulation of lipoprotein lipid oxidation”
(GO:0060587, p = 0.046) and “Lipoprotein lipid oxidation”
(GO:0034439, p = 0.046) pathways were also enriched.
Infection-enriched biological pathways in the epididymal AT
Table 5 presents the Aa infection-enriched biological
pathways in the epididymal AT transcriptome. Compared
with the control mice, in the epididymal AT, infection
enriched the following humoral antibody response and
inflammation-associated pathways: “Antigen binding”
(GO:0003823, p < 0.001), “Antibacterial humoral re-
sponse” (GO:0019731, p = 0.002), “Antimicrobial humo-
ral response” (GO:0019730, p = 0.002), “Immunoglobulin
mediated immune response” (GO:0016064, p = 0.004),
“Humoral immune response mediated by circulating
immunoglobulin” (GO:0002455, p = 0.013), and “Inflam-
matory response” (GO:0006954, p = 0.049). The lipid
homeostasis-related “Monocarboxylic acid metabolic
process” (GO:0032787, p = 0.006), “Fatty acid biosynthetic
process” (GO:0006633, p = 0.006), “Regulation of lipid
metabolic process” (GO:0019216, p = 0.012), “Negative
regulation of lipid metabolic process” (GO:0045833, p =
0.015), “Triglyceride metabolic process” (GO:0006641, p =
0.027), and “Regulation of lipid biosynthetic process”
(GO:0046890, p = 0.032) were also enriched.
Table 6 presents the Cpn infection-enriched pathways
in the epididymal AT transcriptome. The enriched path-
ways included “Very long-chain fatty acid metabolic
Table 2 A. actinomycetemcomitans infection-enriched GO terms in the inguinal AT transcriptome
GO category Enriched
GO term
GO term
p-valuea
GO term-associated gene products
Up-regulatedb Down-regulatedb
GO:0005515 Protein binding <0.001 Spon2, S100a8, Ltf, Des, Retnlg, D6Mit97, LOC100047788, Igl, Igh-
V11, Ighg3, Igkv12-46, Igkv5-48, Igkv13-84, Igkv19-93, Igkv15-103
Zbtb7a, Rhob, Aldh1a1, Ywhag,
Ccdc6, Ptplb, Antxr1, Timp4, Rps3a,
Ddr2, Cidea, Nr1d2, G0s2, Lep, Acta1
GO:0019731 Antibacterial
humoral
response
0.009 LOC100047788 -
GO:0019730 Antimicrobial
humoral
response
0.009 LOC100047788 -
GO:0003823 Antigen
binding
0.009 Igkv5-48, LOC100047788 -
aP-values are corrected for multiple hypotheses using Benjamini-Hochberg false discovery rate.
bFold change limit 2.0.
Number of biological replicates is 3.
GO, gene ontology. The maximum of 20 GO categories is shown.
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metabolic process” (GO:0001676, p = 0.003), “Long-chain
fatty acid-CoA ligase activity” (GO:0004467, p <0.001),
and “Very long-chain fatty acid-CoA ligase activity”
(GO:0031957, p <0.001) pathways. The most affected
pathway was “Defense response” (GO:0006952, p = 0.003).Table 3 C. pneumoniae infection-enriched GO terms in the ing
GO category Enriched GO term GO
p-
GO:0035634 Response to stilbenoid <
GO:0019785 ISG15-specific protease activity <
GO:0032020 ISG15-protein conjugation <
GO:0001823 Mesonephros development 0
GO:0033687 Osteoblast proliferation 0
GO:0035116 Embryonic hindlimb morphogenesis 0
GO:2000543 Positive regulation of gastrulation 0
GO:0061029 Eyelid development in camera-type eye 0
GO:0060272 Embryonic skeletal joint morphogenesis 0
GO:0048793 Pronephros development 0
GO:0030282 Bone mineralization 0
GO:0001656 Metanephros development 0
GO:0042474 Middle ear morphogenesis 0
GO:0004221 Ubiquitin thiolesterase activity 0
GO:0035115 Embryonic forelimb morphogenesis 0
GO:0030501 Positive regulation of bone mineralization 0
GO:0048523 Negative regulation of cellular process 0
GO:0030163 Protein catabolic process 0
GO:0050678 Regulation of epithelial cell proliferation 0
GO:0043401 Steroid hormone mediated signaling pathway 0
aP-values are corrected for multiple hypotheses using Benjamini-Hochberg false dis
bFold change limit 2.0.
Number of biological replicates is 3.
GO, gene ontology. The maximum of 20 GO categories is shown.Table 7 presents the Cpn +Aa infections-enriched path-
ways in the epididymal AT transcriptome. The “Protein
binding” pathway (GO:0005515, p <0.001) included the
highest number of affected genes. Inflammation-related
“Antigen binding” (GO:0003823, p < 0.001), “Antibacterial
humoral response” (GO:0019731, p = 0.016), anduinal AT transcriptome
term
valuea
GO term-associated gene products
Up-regulatedb Down-regulatedb
0.001 Ifit3, Usp18 -
0.001 Usp18 -
0.001 Usp18 -
.001 Osr2, Gpc3 -
.002 Osr2, Eif2ak2 -
.003 Osr2, Gpc3 -
.008 Osr2 -
.008 Osr2 -
.008 Osr2 -
.008 Osr2 -
.013 Osr2, Gpc3 -
.013 Osr2, Gpc3 -
.020 Osr2 -
.020 Usp18 -
.030 Osr2 -
.030 Osr2 -
.036 Slfn1, Gpc3, Ppap2b, Eif2ak2, Osr2 Acaa2, Ddit4
.042 Usp18, Gpc3 -
.042 Osr2, Gpc3 -
.042 - Nr1d2
covery rate.
Table 4 Combined chronic C. pneumoniae and recurrent A. actinomycetemcomitans infections-enriched GO terms in the
inguinal AT transcriptome
GO category Enriched GO term GO term
p-valuea
GO term-associated gene products
Up-regulatedb Down-regulatedb
GO:0005515 Protein binding <0.001 Igk-V5, Igkv5-48, Igkv4-80, Igkv8-30, IgkV33, Igkv12-89, Igkv15-
103, Igkv2-112, D6Mit97, S100a8, Ltf, LOC637260, LOC626347,
Igl, Ighv1-62, Ighv6-3, LOC630305, Ighg3, Igh-4,Ighg,
LOC100047788, Gm16971, Ngp, Chi3l3
Aldh1a1, Adh7, Ddx17,
Acta1, Bmp3, Igfbp6,
Tnnc2, Lep, Dpt
GO:0003823 Antigen binding <0.001 LOC100047788, Igkv5-48, Igkv2-112 -
GO:0019731 Antibacterial humoral
response
0.002 LOC100047788 -
GO:0019730 Antimicrobial humoral
response
0.002 LOC100047788 -
GO:0051952 Regulation of amine transport 0.002 - Lep, Sncg
GO:0042572 Retinol metabolic process 0.011 - Aldh1a1, Adh7
GO:0030534 Adult behavior 0.011 - Lep, Sncg
GO:0014059 Regulation of dopamine
secretion
0.011 - Sncg
GO:0014046 Dopamine secretion 0.011 - Sncg
GO:0006836 Neurotransmitter transport 0.011 - Slc6a13, Sncg
GO:0042573 Retinoic acid metabolic
process
0.013 - Aldh1a1, Adh7
GO:0002455 Humoral immune response
mediated by circulating
immunoglobulin
0.016 LOC100047788 -
GO:0046928 Regulation of
neurotransmitter secretion
0.020 - Sncg
GO:0008344 Adult locomotory behavior 0.042 - Sncg
GO:0032526 Response to retinoic acid 0.044 - Aldh1a1, Lep
GO:2000366 Positive regulation of STAT
protein import into nucleus
0.046 - Lep
GO:0071298 Cellular response to L-
ascorbic acid
0.046 - Lep
GO:0060587 Regulation of lipoprotein lipid
oxidation
0.046 - Lep
GO:0051956 Negative regulation of amino
acid transport
0.046 - Lep
GO:0034439 Lipoprotein lipid oxidation 0.046 - Lep
aP-values are corrected for multiple hypotheses using Benjamini-Hochberg false discovery rate.
bFold change limit 2.0.
Number of biological replicates is 3.
GO, gene ontology. The maximum of 20 GO categories is shown.
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pathways were enriched. There were no enrichments in
lipid metabolism-related pathways.
Inflammation- and lipid homeostasis-related up- and
down-regulated genes in the inguinal AT
In Aa group, most of the “Protein binding” pathway-
associated up-regulated genes belonged to immunoglobulin
variables (Table 2, Additional file 2: Table S2). The most
up-regulated genes were S100 calcium binding protein A8
(S100a8, FC = 13.27), S100 calcium binding protein A9
(S100a9, FC = 9.45), and lactotransferrin (Ltf, FC = 6.62).Lipid homeostasis-associated leptin (Lep, FC = 0.46) was
down-regulated (Additional file 2: Table S2).
In Cpn group, infection induced down-regulation of
acetyl-Coenzyme A acyltransferase 2 (Acaa2, FC =
0.41), ELOVL family member 6, elongation of long
chain fatty acids (Elovl6, FC = 0.44), and nuclear recep-
tor subfamily 1, group D, member 2 (Nr1d2, FC = 0.44)
(Additional file 3: Table S3).
In Cpn + Aa group, the majority of up-regulated genes
were immunoglobulin variables (Additional file 4: Table
S4). In addition, S100a9 (FC = 11.29), S100a8 (FC =
10.96), and Ltf (FC = 4.73) were up-regulated. Lep (FC =
Table 5 A. actinomycetemcomitans infection-enriched GO terms in the epididymal AT transcriptome
GO category Enriched GO term Go term
p-valuea
GO term-associated gene products
Up-regulatedb Down-regulatedb
GO:0003823 Antigen binding <0.001 Igk-C, LOC100047788 -
GO:0019731 Antibacterial humoral response 0.002 LOC100047788 -
GO:0019730 Antimicrobial humoral response 0.002 LOC100047788 -
GO:0016064 Immunoglobulin mediated immune response 0.004 LOC100047788 Bcl6
GO:0032787 Monocarboxylic acid metabolic process 0.006 Pcx, Insig1, Elovl6, Scd2 -
GO:0006633 Fatty acid biosynthetic process 0.006 Insig1, Elovl6, Scd2 -
GO:0019216 Regulation of lipid metabolic process 0.012 Cidea, Insig1, Thrsp -
GO:0002455 Humoral immune response mediated by
circulating immunoglobulin
0.013 LOC100047788 -
GO:0045833 Negative regulation of lipid metabolic process 0.015 Cidea, Insig1 -
GO:0005515 Protein binding 0.022 Slc15a2, Cidea, Thrsp, Elovl6,
Lrtm1, Igk-V5, LOC384413,
LOC637227, Insig1, LOC100047162,
LOC669053, Igk-C, LOC100047628,
LOC100047788, Ighg, Ighg3, LOC676136
Bcl6, Itga11
GO:0006641 Triglyceride metabolic process 0.027 Thrsp, Insig1 -
GO:0046890 Regulation of lipid biosynthetic process 0.032 Thrsp, Insig1 -
GO:0009611 Response to wounding 0.034 Fabp4, Klf6 Chst4, Bcl6
GO:0001816 Cytokine production 0.045 Fabp4, Cidea Bcl6
GO:0001818 Negative regulation of cytokine production 0.046 Cidea Bcl6
GO:0051973 Positive regulation of telomerase activity 0.048 9130213B05Rik -
GO:0042938 Dipeptide transport 0.048 Slc15a2 -
GO:0006954 Inflammatory response 0.049 Fabp4 Chst4, Bcl6
aP-values are corrected for multiple hypotheses using Benjamini-Hochberg false discovery rate.
bFold change limit 2.0.
Number of biological replicates is 3.
GO, gene ontology. The maximum of 20 GO categories is shown.
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http://www.biomedcentral.com/1471-2164/14/7090.46) and synuclein δ (Sncg, FC = 0.040) were down-
regulated (Additional file 4: Table S4).
Inflammation- and lipid homeostasis-related up- and
down-regulated genes in the epididymal AT
In Aa group, the enriched “Monocarboxylic acid metabolic
process” pathway (p = 0.006) included four up-regulated
genes: pyruvate carboxylase (Pcx, FC = 2.82), Elovl6 (FC =
3.21), stearoyl-coenzyme A desaturase 2 (Scd2, FC = 2.15),
and insulin induced gene 1 (Insig1, FC = 2.01) (Additional
file 5: Table S5). Insig1, cell death-inducing DNA fragmen-
tation factor, alpha subunit-like effector A (Cidea, FC =
2.53) and thyroid hormone responsive (Thrsp, FC = 2.26)
were associated with the “Regulation of lipid metabolic
process” pathway (p = 0.012). In addition, fatty acid binding
protein 4 (Fabp4, FC = 2.60) and immunoglobulin variables
were up-regulated (Additional file 5: Table S5).
In Cpn group, the “Defense response” pathway (p =
0.003) included four defensin subtypes, 5′ nucleotidase,
ecto (Nt5e, FC = 3.34), and chemokine (C-C motif) ligand
8 (Ccl8, FC = 2.81) (Additional file 6: Table S6). The up-
regulated solute carrier family 27 (fatty acid transporter),member 2 (Slc27a2, FC = 3.09) was associated with the
lipid homeostasis-related pathways.
In Cpn +Aa group, a large number of up-regulated
genes were immunoglobulin variables and the most up-
regulated was Ig gamma-2A chain C region secreted
form-like (LOC100047788, FC = 37.73) (Additional file 7:
Table S7). Lipid homeostasis -associated arachidonate 12-
lipoxygenase (Alox12, FC = 3.91) was also up-regulated.The expression of de novo lipogenesis-associated genes
Figure 1 presents the expression of de novo lipogenesis -
associated genes in the AT depot transcriptomes among
the different infection models (the data are derived from
the microarray experiment). In the epididymal transcrip-
tome of Aa-infected mice, the up-regulated genes were
Pcx (FC = 2.82), fatty acid synthase (Fasn, FC = 1.81),
Scd2 (FC = 2.15), and Elovl6 (FC = 3.21) (Figure 1A).
Fasn and Elovl6 were down-regulated in the Cpn group
in both AT depots (inguinal Fasn FC = −2.19, epididymal
Fasn FC = −2.86; inguinal Elovl6 FC = −2.26, epididymal
Elovl6 FC = −1.98) (Figure 1B). The combined infection
Table 6 C. pneumoniae infection-enriched GO terms in the epididymal AT transcriptome
GO category Enriched GO term Go term
p-valuea
GO term-associated gene products
Up-regulatedb Down-regulatedb
GO:0009206 Purine ribonucleoside triphosphate
biosynthetic process
<0.001 Nme7, Atp1b1, Ldhc,1600029I14Rik -
GO:0006754 ATP biosynthetic process <0.001 Nme7, Atp1b1, Ldhc -
GO:0005391 Sodium:potassium-exchanging ATPase activity <0.001 Nme7, Atp1b1 -
GO:0031957 Very long-chain fatty acid-CoA ligase activity <0.001 Acsbg1, Slc27a2 -
GO:0030317 Sperm motility <0.001 Spag6, Tnp1, Ldhc, Smcp -
GO:0004467 Long-chain fatty acid-CoA ligase activity <0.001 Acsbg1, Slc27a2 -
GO:0006952 Defense response 0.003 Ccl8, Arg2, Defb22, Cx3cl1,
Nt5e, Defb29, Defb36,
Defb38, Cfi, Elf3
Ccl5, Orm1, Orm2, S100a8,
Ccl11
GO:0001676 Long-chain fatty acid metabolic process 0.003 Acsbg1, Slc27a2 -
GO:0000038 Very long-chain fatty acid metabolic process 0.003 Acsbg1, Slc27a2 -
GO:0006323 DNA packaging 0.004 Sox9, Prm1 Hist1h4i, Hist2h2ac, Hist1h4k,
Hist1h4j, Hist1h3d
GO:0016338 Calcium-independent cell-cell adhesion 0.005 Cldn2, Cldn11, Cx3cl1
GO:0009991 Response to extracellular stimulus 0.007 Slc39a4, Mt3, Srd5a2,
Sox9, Lrp2, Sfrp1,
Arg2, Avpr1a
Tnfrsf11b, Ccl5, Acta1
GO:0034728 Nucleosome organization 0.008 Sox9, Tnp1 Hist1h3d, Hist2h2ac, Hist1h4i,
Hist1h4k, Hist1h4j
GO:0071345 Cellular response to cytokine stimulus 0.008 Mt3, Cx3cl1, Krt18, Sox9,
Krt8, Sfrp1, Arg2
Ccl5
GO:0042493 Response to drug 0.008 Slc15a2, Mt3, Srd5a2,
Lrp2, Sfrp1, Arg2, Slc22a1
Tnfrsf11b, Ccl5, Cox8b
GO:0048245 Eosinophil chemotaxis 0.009 LOC100048554 Ccl5, Ccl11
GO:0022414 Reproductive process 0.009 Spag6, Sox9, 4931407G18Rik,
Avpr1a, Arg2, Prm1, Tnp1,
Odf2, Smcp, Acsbg1, Cldn11,
Srd5a2, Mycbpap, Sfrp1
Ccl5
GO:0006333 Chromatin assembly or disassembly 0.009 Sox9, Tnp1 Hist1h3d, Hist2h2ac, Hist1h4i,
Hist1h4k, Hist1h4j,
GO:0048609 Multicellular organismal reproductive process 0.010 4931407G18Rik, Avpr1a,
Arg2, Prm1, Spag6, Smcp,
Odf2, Sfrp1, Cldn11, Mycbpap, Sox9, Tnp1
-
GO:0032504 Multicellular organism reproduction 0.010 Sox9, 4931407G18Rik, Arg2, Prm1,
Spag6, Avpr1a, Odf2, Sfrp1,
Cldn11, Tnp1, Mycbpap, Smcp
-
aP-values are corrected for multiple hypotheses using Benjamini-Hochberg false discovery rate.
bFold change limit 2.0.
Number of biological replicates is 3.
GO, gene ontology. The maximum of 20 GO categories is shown.
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ated gene expression (Figure 1C).
Alterations in QPCR-analyzed mRNA expression levels
The relative mRNA expression levels of neutrophil
activation- (Slpi and Mpo) and macrophage phenotype-
(macrophage type 2 marker Mrc-1) and activation- (Mcp-
1 and Mif) related genes in inguinal and epididymal AT
are presented in Table 8. In the inguinal AT, the relative
expression levels of genes encoding Slpi and Mpo weresignificantly higher in the Aa group (Slpi: p = 0.003; Mpo:
p = 0.009) than in control mice (level set to zero in the
analysis). Cpn infection did not have a significant effect
on the selected gene expression levels.
In the epididymal AT, the relative mRNA expression
levels of Mcp-1, Mif, and Slpi in the Aa group, Mrc-1
and CD68 in Cpn group, and Mif in Aa + Cpn group
were significantly altered but between −1 to 1 log2FC .
The Cpn + Aa combination induced a reduction in the
Mcp-1 mRNA levels (p <0.001).
Table 7 Combined chronic C. pneumoniae and recurrent A. actinomycetemcomitans infections-enriched GO terms in the
epididymal AT transcriptome
GO
category
Enriched GO term Go term p-valuea GO term-associated gene products
Up-regulatedb Down-regulatedb
GO:0045653 Negative regulation of
megakaryocyte
differentiation
<0.001 - Hist1h4h, Hist1h4i, Hist1h4k,
Hist1h4j
GO:0006334 Nucleosome assembly <0.001 Sox9 Hist1h4j, Hist1h4i, Hist1h4k,
Hist1h4h, Hist1h3d, Hist2h2ac
GO:0005515 Protein binding <0.001 BC021891, Lrrc48, Gja1, Cldn2, Lrtm1, Pcp4l1, Cldn11,
Ubd, Dynlrb2, Mt3, Clic6, Sh3gl2, Lrp2, Nme7, Slc40a1,
Cxcl13, Fcgr4, Spag6, Ccl8, Sox9, Alox12, Sfrp1, Ighv1-62,
Col6a5, C7, Ighg3, Ighg, LOC100047788, Igk-C, D6Mit97,
Igk-V5, Igkv12-46, LOC384419, LOC637227, Igkv4-68
Itga11, Acta1, Bmp3, Sfrp5,
Hist1h4i, Hist1h4h, Hist1h4k,
Wdr92, Hist1h3d, Hist1h4j
GO:0003823 Antigen binding <0.001 LOC100047788, Igk-C -
GO:0016337 Cell-cell adhesion 0.004 Sox9, Cxcl13, Cldn11, 1110049B09Rik, Cldn2, Dsg2 Chst4
GO:0016338 Calcium-independent
cell-cell adhesion
0.011 Cldn2, Cldn11 -
GO:2000117 Negative regulation of
cysteine-type
endopeptidase activity
0.016 Sfrp1, Mt3 -
GO:0019731 Antibacterial humoral
response
0.016 LOC100047788 -
GO:0019730 Antimicrobial humoral
response
0.016 LOC100047788 -
GO:0008219 Cell death 0.016 Mt3, Alox12, Sox9, Slc40a1, Sfrp1, Acsbg1, Mmd2, Ubd,
Bex2, Dsg2, Gja1
Lyz1, Wdr92
GO:0071504 Cellular response to
heparin
0.021 Sfrp1, Sox9 -
GO:0006352 Transcription initiation,
DNA-dependent
0.021 - Hist1h4h, Hist1h4i, Hist1h4k,
Hist1h4j
GO:0019835 Cytolysis 0.024 Mmd2 Lyz1
GO:0008253 5′-nucleotidase activity 0.041 Nt5e, Acpp -
aP-values are corrected for multiple hypotheses using Benjamini-Hochberg false discovery rate.
bFold change limit 2.0.
Number of biological replicates is 3.
GO, gene ontology. The maximum of 20 GO categories is shown.
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The proportions of fatty acids in the epididymal and in-
guinal AT are presented in Figure 2. In the inguinal AT,
Aa infection induced a significantly higher proportion of
SFAs (Aa group: p = 0.027; Cpn + Aa group: p = 0.009;
Figure 2A) and a lower proportion of PUFAs (Aa group:
p = 0.006; Cpn + Aa group: p = 0.022; Figure 2C) com-
pared to the control mice. The proportion of MUFAs
was greater in the Cpn group (p = 0.018; Figure 2B).
In the epididymal AT, the proportions of SFAs were
higher among all infected mice but the difference
reached statistical significance only in the Aa group (p =
0.003; Figure 2A). The proportion of PUFAs was signifi-
cantly lower in the Aa (p = 0.005) and Cpn + Aa groups
(0.016) (Figure 2C). When the two AT depots were com-
pared, the proportion of SFAs was lower in the epididy-
mal AT than in the inguinal AT in the control group
(17.1 ± 1.8 vs. 20.7 ± 2.1% of total FA, respectively;p = 0.002) and the Aa + Cpn group (19.0 ± 2.3 vs. 24.2 ±
3.0% of total FA, respectively; p = 0.001).
Associations between serum and AT parameters
The associations between different serum and AT var-
iables were determined by correlation analysis (data
from all infection models and the controls combined)
and presented as graphs in Figure 3. Serum LPS ac-
tivity correlated positively with the serum FFA con-
centration (p < 0.001, Figure 3A) and with the
proportion of SFA in the epididymal AT (p = 0.030,
Figure 3B), and negatively with both inguinal (p = 0.045,
Figure 3D) and epididymal (p = 0.013, Figure 3C) propor-
tions of PUFA.
Discussion
In the present study, we examined the inflammation-
and lipid homeostasis-related effects of systemic A.
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Figure 1 The expression of de novo lipogenesis associated
genes among different AT depots and infection models. The
gene expression fold changes were calculated from the microarray
analysis data as described in the Methods section. Differences in
gene expression in the inguinal and epididymal AT transcriptomes
induced by A) recurrent A. actinomycetemcomintas infection, B)
chronic C. pneumoniae infection and C) combined recurrent A.
actinomycetemcomintas and C. pneumoniae infections. The changes
were statistically non-significant after false discovery rate correction.
Acaca, acetyl-Coenzyme A carboxylase alpha; Elovl6, ELOVL family
member 6, elongation of long chain fatty acids (yeast); Fasn, fatty
acid synthase; Pcx, pyruvate carboxylase; Pparg, peroxisome
proliferator activated receptor γ; Scd1, stearoyl-Coenzyme A
desaturase 1; Scd2, stearoyl-Coenzyme A desaturase 2.
Table 8 Relative changes in mRNA expression levels of
selected genes in inguinal and epididymal AT
Aa group Cpn group Cpn + Aa group
(n = 10) (n = 10) (n = 10)
Tissue Gene Median Log2 fold change (IQRs)
a
p-valueb
Inguinal AT Mcp-1 −0.78 (1.96) −0.31 (1.44) −0.53 (1.76)
0.671 0.348 0.020
Mrc-1 −0.19 (1.05) −0.17 (1.00) 0.02 (2.08)
0.671 1.000 1.000
CD68 0.44 (1.56) 0.25 (1.23) 0.03 (1.36)
0.203 0.061 0.437
Mif 0.57 (2.15) 0.40 (1.94) −0.11 (1.67)
0.203 0.348 1.000
Slpi 4.73 (2.99) −1.18 (3.55) 2.79 (6.50)
0.003 0.061 0.437
Mpo 4.30 (2.64) −0.48 (3.75) 4.04 (7.01)
0.009 0.115 0.348
Epididymal AT Mcp-1 −0.73 (1.97) −0.41 (1.88) −1.03 (1.46)
0.020 0.203 <0.001
Mrc-1 −0.16 (0.88) 0.60 (0.53) −0.17 (0.99)
0.437 0.003 0.599
CD68 −0.39 (0.90) 0.58 (0.76) 0.55 (1.86)
0.120 0.034 0.600
Mif −0.88 (0.70) −0.13 (1.06) −0.86 (0.67)
0.020 0.203 <0.001
Slpi −0.89 (2.11) 0.20 (2.20) −0.24 (2.07)
0.002 0.203 0.600
aMedian Log2 fold change (IQRs) to the control mice. The control mice have
been set into the value of 0.
bThe Mann–Whitney U Test with the control mice as the reference group.
Aa group, recurrent A. actinomycetemcomitans infection; Cpn group, chronic C.
pneumoniae infection; Cpn + Aa group, combined recurrent A.
actinomycetemcomitans and chronic C. pneumoniae infections; IQR,
interquartile range; Mcp-1, monocyte chemoattractant protein 1; Mif,
macrophage migration inhibitory factor, Mrc-1, mannose receptor C type 1;
Mpo, myeloperoxidase; Slpi, secretory leukocyte peptidase inhibitor.
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http://www.biomedcentral.com/1471-2164/14/709actinomycetemcomitans and C. pneumoniae infections
on AT derived from chow-fed apoE-deficient mice.
These effects were examined on gene expression and
fat composition level in both inguinal and epididymal
AT depots. Recurrent Aa infection affected both ATdepots significantly: inflammation-related biological
pathways were enriched in inguinal AT and both
inflammation- and lipid homeostasis-related pathways
were enriched in epididymal AT. AT fat distribution
was altered and SFAs were increased at the expense
of PUFAs in both epididymal and inguinal AT among
all A. actinomycetemcomitans-infected mice. The im-
pact of chronic C. pneumoniae infection on AT de-
pots was less prominent.
The mouse models used in the present study were
designed to display chronic infections. Our Aa model is
characterized by endotoxemia and systemic inflammation.
The observed increased humoral immune responses can be
somewhat expected, because we have previously shown that
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Figure 2 Proportions of fatty acids in inguinal and epididymal
AT. The AT FAs were analyzed by gas liquid chromatography as
described in the Methods section. The results are expressed as
percentage of weight normalized to 100%. Proportions of A) SFAs,
B) MUFAs, and C) PUFAs in inguinal and epididymal AT. The
statistical significance of differences was determined with Mann–
Whitney U Test using the respective control group as the reference
group. *, p <0.05; ** p <0.01; AT, adipose tissue; FA, fatty acid; MUFA,
monounsaturated fatty acid; PUFA, polyunsaturated fatty acid; SFA,
saturated fatty acid.
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http://www.biomedcentral.com/1471-2164/14/709the serum levels of LPS activity, TNFα, and IgG antibodies
against A. actinomycetemcomitans after 10 intravenous in-
jections of live bacteria are significantly higher in the Aa
group compared with the control group [19,20]. The per-
sistence of C. pneumonia after three inoculations was also
shown as the pathogen was recovered from the lungs of the
mice [20]. Since atherosclerosis is a multiorgan disease, our
aim was to broaden the study from the lipid depots in heart
and liver to adipose tissue, which plays an important role in
sustaining systemic inflammation and proatherogenic lipid
profile.Experimental acute endotoxemia has been shown to
induce general insulin resistance and local and adaptive
inflammation in human subcutaneous AT [27]. In our
study, Aa infection enriched inflammation-related path-
ways in the inguinal AT. QPCR analysis verified up-
regulated expression of Mpo and Slpi, and the most up-
regulated genes in the microarray analysis were S100a8
and Ltf. These innate immunity-associated gene prod-
ucts are considered anti-inflammatory mediators and
they exhibit various antimicrobial functions such as pro-
motion of oxidative activity responses [28-30]. Human
Slpi and Ltf have been shown to co-localize in secondary
granules and they are co-released after neutrophil activa-
tion [31]. Interestingly, increased plasma Slpi levels were
associated with progressive metabolic dysfunction in
men [32]. Despite the up-regulation in neutrophil
activation-related genes, we did not observe changes in
the mRNA expression of genes associated with classic-
ally or alternatively activated macrophages. The response
of Aa infection in the epididymal AT was quite distinct.
As in inguinal AT, the humoral antibacterial response
and immunoglobulin-related pathways were enriched.
However, the myeloid cell-specific signs of enhanced
oxidative stress were absent, expression of Slpi was
somewhat down-regulated and, instead, several lipid
homeostasis-related biological pathways were enriched.
On AT fatty acid level, we observed a potentially adverse
increase in the proportion of SFAs among all Aa-infected
mice. Mengting et al. 2010 reported that compared with
lean mice, obese mice have a higher level of SFAs in their
epididymal AT [33]. An interesting study by Suganami et al.
2007 demonstrated that SFAs released by hypertrophied ad-
ipocytes activate the NF-κB pathway in the macrophages
with ensuing TNF-α release [34]. The subsequent lipolytic
release of SFAs creates a positive feed-back loop between
adipocytes and macrophages. Importantly, the macrophage-
derived TNF-α also resulted in NF-κB-dependent release of
proinflammatory cytokines from the adipocytes. Both LPS
and SFA have been shown to generate endoplasmic
reticulum stress in primary human adipocytes [35]. Elevated
levels of SFAs in both epididymal and inguinal AT depots
in the Aa and Cpn +Aa groups suggested an increased
proinflammatory potential of these AT depots. In addition,
because PUFAs have been reported to inhibit the
TLR dimerization induced by SFAs [36], the sig-
nificantly decreased proportion of PUFAs among all A.
actinomycetemcomitans-infected mice may intensify the ef-
fects of increased SFAs. The proportion of PUFAs also
showed a significant inverse association with LPS serum ac-
tivity. This result may be due to LPS-triggered enhanced
oxidative stress in the AT, followed by the peroxidation of
PUFAs. In addition to intracellular effects, LPS has been
shown to elevate the levels of circulating FFAs in rodents
in vivo [37]. This association was also found in our study as
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Figure 3 Correlations between serum and AT parameters. Bivariate correlations were determined using the Spearman test. A) Concentration
of serum free fatty acids (mg/dl) and serum LPS activity (EU), B) serum LPS activity (EU) and epididymal SFAs (wt%), C) serum LPS activity (EU)
and epididymal PUFAs (wt%), and D) serum LPS activity (EU) and inguinal PUFA s(wt%). EU, ELISA units; LPS, lipopolysaccharide; PUFA,
polyunsaturated fatty acid; SFA, saturated fatty acid.
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http://www.biomedcentral.com/1471-2164/14/709there was a strong positive correlation between serum LPS
activity and the FFA level.
Lipid homeostasis-related biological pathways were
enriched and four important de novo lipogenesis-related
genes were moderately up-regulated in the epididymal
AT in Aa group. The observed up-regulation of Pcx and
Fasn could partially explain the increase in the SFA pro-
portion. However, up-regulation of de novo lipogenesis
genes was not observed in Cpn and Cpn + Aa groups,
indicating the involvement of other regulatory pathways
affecting SFA levels in the AT.
Chronic infection with C. pneumoniae did not enhance
the pathways associated with humoral antibody response,
and moreover, the effects on the AT depot fatty acid distri-
bution were less evident than with Aa infection. However,
the “Defense response” pathway which included four up-
regulated defensins was enriched in the epididymal AT
depot. Previously, C. pneumoniae infection in vitro was
reported to induce human β-defensin 2 productionmediated by the TLR4 pathway in monocytes [38]. Al-
though both C. pneumoniae and A. actinomycetemcomitans
are Gram-negative pathogens, the effects of Cpn infection
differed considerably from those of Aa infection. This result
may be due to the distinct infection routes and C.
pneumoniae being an obligatory intracellular pathogen. In
addition, the difference in the infection time points may
also influence the outcome and, altogether, the character of
chronic infection differs from the recurrent one. The com-
bined infection model displayed a humoral antibody re-
sponse and changes in AT depot FA distribution similar to
those with single Aa infection. Nevertheless, indicators of
the potentially amplified de novo lipogenesis in epididymal
AT remained absent.
The major limitation of the study was the small num-
ber of mice available for the microarray analysis, which
resulted in non-significant gene FC-results after FDR
correction. Although the apoE-deficient mouse model
has been utilized widely in atherosclerosis research, it
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http://www.biomedcentral.com/1471-2164/14/709possesses certain drawbacks, such as a somewhat non-
physiological lipoprotein profile [39]. The adipocytes of
apoE-deficient mice are smaller, contain fewer lipids,
and accumulate less triglycerides from very low-density
lipoproteins and chylomicrons compared with adipo-
cytes derived from wild-type mice [40,41]. In addition,
because apoE has been shown to protect against LPS-
derived sepsis, apoE deficiency actually exposes mice to
the deleterious and possibly proatherogenic effects of
LPS [21]. Nevertheless, the augmented susceptibility to
LPS may produce a more human-like response, because
rodents are generally more resistant to LPS-mediated ef-
fects than humans. Our study design included only
males and therefore we could only draw gender-specific
conclusions. It is noteworthy that, in mice, approxi-
mately 20% of AT genes exhibit sexual dimorphism (FC
>1.2), and the enriched functional categories with FC >3
include “Lipid metabolism” [42].
Conclusions
The present study introduces in vivo evidence that sys-
temic infection of A. actinomycetemcomitans activates
inflammation-related biological pathways and alters the
lipid homeostasis adversely in both inguinal and epididy-
mal AT depots in apoE-deficient mice. The results
suggest that repeated endotoxemia promotes AT dys-
function as shown by accumulation of saturated fat in
the tissue and spill-over of free fatty acids into the circu-
lation possibly via induced lipolysis. These observations
may be useful when studying the potential mechanism
linking adipose tissue to the proposed atherogenicity of
the chronic infections.
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